Clinically Approved Antibiotics from 2010 to 2022

Authors

DOI:

https://doi.org/10.2533/chimia.2023.230

PMID:

38047802

Keywords:

Antibiotics, Antimicrobial resistance, Natural products, Semisynthesis, Tuberculosis

Abstract

This review discusses small molecule antibiotics approved for clinical use in the time frame 2010-2022. This time span saw the approval of four synthetic antibiotics (bedaquiline, pretomanid, delafloxacin, tedizolid), nine natural product derivatives (ceftaroline fosamil, cefiderocol, plazomicin, omadacycline, eravacycline, sarecycline, lefamulin, dalbavancin, oritavancin), and one natural product (fidaxomicin).

Funding data

Downloads

Published

2023-04-26

How to Cite

[1]
E. Jung, K. Gademann, Chimia 2023, 77, 230, DOI: 10.2533/chimia.2023.230.